These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8808068

  • 1. Percutaneous transluminal coronary angioplasty: comparison of arterial vs. venous activated clotting time.
    Pesola GR, Johnson A, Pesola DA.
    Cathet Cardiovasc Diagn; 1996 Feb; 37(2):140-4. PubMed ID: 8808068
    [Abstract] [Full Text] [Related]

  • 2. Activated clotting time differential is a superior method of monitoring anticoagulation following coronary angioplasty.
    Pitney MR, Kelly SA, Allan RM, Giles RW, McCredie M, Walsh WF.
    Cathet Cardiovasc Diagn; 1996 Feb; 37(2):145-50. PubMed ID: 8808069
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of arterial versus venous-activated clotting time in patients with congenital heart disease undergoing cardiac catheterization.
    Zeevi B, Bar-Mor G, Livne M, Berant M.
    Catheter Cardiovasc Interv; 1999 Feb; 46(2):194-6. PubMed ID: 10348542
    [Abstract] [Full Text] [Related]

  • 5. [-Value of activated blood coagulation time in monitoring anticoagulation during coronary angioplasty-].
    Kunert M, Sorgenicht R, Scheuble L, Ketteler T, Lürken E, Meyer I, Müller A, Emmerich K, Gülker H.
    Z Kardiol; 1996 Feb; 85(2):118-24. PubMed ID: 8650981
    [Abstract] [Full Text] [Related]

  • 6. A comparison between arterial- and venous-sampled activated clotting time measurements.
    Zisman E, Rozenberg B, Katz Y, Ziser A.
    Isr J Med Sci; 1997 Dec; 33(12):786-8. PubMed ID: 9464347
    [Abstract] [Full Text] [Related]

  • 7. [The use of activated clotting time (ACT) to optimize heparinization during coronary angioplasty. The nursing personnel of the Hemodynamics Laboratory].
    Dellavalle A, Steffenino G, Ribichini F, Russo P, Conte L, Conte E, Uslenghi E.
    G Ital Cardiol; 1995 Apr; 25(4):445-51. PubMed ID: 7642051
    [Abstract] [Full Text] [Related]

  • 8. Heparin dosing for percutaneous coronary angioplasty: use of body surface area to improve initial activated clotting time values.
    Pesola GR, Pesola DA.
    Clin Cardiol; 1997 Dec; 20(12):1006-9. PubMed ID: 9422838
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. When we "act" on ACT levels: activated clotting time measurements to guide heparin administration during and after interventional procedures.
    Klein LW, Agarwal JB.
    Cathet Cardiovasc Diagn; 1996 Feb; 37(2):154-7. PubMed ID: 8808071
    [Abstract] [Full Text] [Related]

  • 11. Relationship between arterial and venous activated partial thromboplastin time values in patients after percutaneous transluminal coronary angioplasty.
    Rudisill PT, Moore LA.
    Heart Lung; 1989 Sep; 18(5):514-9. PubMed ID: 2528519
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heparin monitoring during coronary intervention: activated clotting time versus activated partial thromboplastin time.
    Nath FC, Muller DW, Rosenschein U, Ellis SG, Topol EJ.
    Can J Cardiol; 1993 Nov; 9(9):797-801. PubMed ID: 8281479
    [Abstract] [Full Text] [Related]

  • 15. Accuracy of drawing coagulation samples from heparinized arterial lines.
    Templin K, Shively M, Riley J.
    Am J Crit Care; 1993 Jan; 2(1):88-95. PubMed ID: 8353585
    [Abstract] [Full Text] [Related]

  • 16. Six hour ambulation after elective coronary angioplasty and stenting with 7F guiding catheters ald low dose heparin.
    Tengiz I, Ercan E, Bozdemir H, Durmaz O, Gurgun C, Nalbantgil I.
    Kardiol Pol; 2003 Feb; 58(2):93-7. PubMed ID: 14504634
    [Abstract] [Full Text] [Related]

  • 17. Clinical safety and cost of heparin titration using bedside activated clotting time.
    Thomason T, Riegel B, Jessen D, Smith SC, Gocka I, Rich M.
    Am J Crit Care; 1993 Jan; 2(1):81-7. PubMed ID: 8353584
    [Abstract] [Full Text] [Related]

  • 18. Comparison of activated clotting times to heparin management test for adequacy of heparin anticoagulation in percutaneous transluminal coronary angioplasty.
    Helft G, Choktron S, Beygui F, Le Feuvre C, Elalamy I, Metzger JP, Vacheron A, Samama MM.
    Cathet Cardiovasc Diagn; 1998 Nov; 45(3):329-31. PubMed ID: 9829899
    [Abstract] [Full Text] [Related]

  • 19. Immediate femoral sheath removal after 6 French routine coronary angioplasty with a weight-adjusted low-dose heparin: results of a prospective registry.
    Metz D, Brasselet C, Tabet E, Nazeyrollas P, Tassan-Mangina S, Deschildre A, Elaerts J, Blaise C.
    J Invasive Cardiol; 1999 Jul; 11(7):416-20. PubMed ID: 10745564
    [Abstract] [Full Text] [Related]

  • 20. Research review: use of activated clotting time to monitor heparin therapy in coronary patients.
    Noureddine SN.
    Am J Crit Care; 1995 Jul; 4(4):272-7; quiz 278-9. PubMed ID: 7663590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.